UBS analyst Rory McKenzie upgraded Adecco (AHEXY) to Neutral from Sell with a price target of CHF 21, down from CHF 22. The firm sees the company’s earnings stabilizing in the near-term.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHEXY:
- Adecco Group Earnings Call Highlights Profitable Turnaround
- Adecco price target lowered to CHF 21 from CHF 22.50 at Morgan Stanley
- Balanced Risk-Reward and Margin Pressures Justify Hold Rating on Adecco
- AHEXY Earnings this Week: How Will it Perform?
- Adecco announces acquisition of Advantis Medical Staffing